Urothelial Bladder Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Urothelial Bladder Cancer
Research To Practice | Oncology Videos · Dr. Neil Love
February 9, 20241h 59m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Matthew Milowsky, Dr Peter H O'Donnell, Dr Jonathan E Rosenberg and Dr Arlene Siefker-Radtke, moderated by Dr Evan Y Yu, including the following topics:
- Introduction (0:00)
- Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Milowsky (2:54)
- Other Novel Strategies Under Investigation for Nonmetastatic UBC — Dr O'Donnell (25:53)
- Front-Line Treatment for Metastatic UBC (mUBC) — Dr Rosenberg (49:43)
- Emerging Role of HER2-Targeted Therapy for mUBC — Dr Yu (1:12:03)
- Selection and Sequencing of Therapy for Relapsed/Refractory mUBC — Dr Siefker-Radtke (1:35:51)
CME information and select publications